Sisätautien klinikka

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Abrahamsson P et al. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.
2 Airaksinen J. Tekoläppäpotilaan seuranta .
3 Airaksinen J. Aikuisten viattomat sydämen sivuäänet .
4 Airaksinen J . Aikuisen yleisimmät hankitut läppäviat ja niihin liittyvät sivuäänet .
5 Airaksinen J et al. DRG kardiologiassa - onko keisarilla edes vaatteita? .
6 Allen LA et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program .
7 Anker SD et al. Prevalence, incidence and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial .
8 Avivi I et al. Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
9 Borra RJH. Nonalcoholic Fatty Liver Disease in Obesity and Type 2 Diabetes. . Studies sing 1H MRS and PET .
10 Borra RJH et al. Nonalcoholic fatty liver disease: Rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging .
11 Brügger-Andersen T et al. Moderate alcohol consumption in associated with reduced long-term cardiovascular risk in patients following a complicated acute myocardial infarction.
12 Cacoub PP et al. Patients with peripheral atrerial disease in the CHARISMA trial .
13 Chumaeva N et al. Chronic stress and the development of early atherosclerosis: moderating effect of endothelial dysfunction and impaired arterial elasticity.
14 Chumaeva N et al. Interactive effect of long-term mental stress and cardiac stress reactivity on carotid intima-media thickness: The Cardiovascular Risk in Young Finns study.
15 Connolly SJ et al. Dabigatran versus warfarin in patients with atrial fibrillation.
16 Cowan BR et al. Left ventricular mass and volume with telmisartan, ramipril or combination in patients with previous atherosclerotic events or with diabetes mellitus.
17 Cowan BR et al. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics .
18 Cukierman-Yaffe T et al. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme.
19 Dasgupta A et al. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (A post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance trial).
20 Duodecimin ja Suomen Kardiologisen Seuran asettama työryhmä et al. Käypä hoito -suositus: Sepelvaltimotautikohtaus: epästabiili angina pectoris ja sydäninfarkti ilman ST-nousuja ja - vaaran arviointi ja hoito .
21 Duodecimin ja Suomen sisätautilääkärien yhdistys ry:n asettama työryhmä et al. Käypä hoito -suositus: Dyslipidemiat.
22 Duodecimin ja Suomen Verenpaineyhdistys ry:n asettama työryhmä et al. Käypä hoito -suositus: Kohonnut verenpaine .
23 Erglis A et al. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
24 Fan M et al. The association between cigarette smoking and carotid intima-media thickness is influenced by the -930A/G CYBA gene polymorphism: The Cardiovascular Risk in Young Finns Study.
25 Fan Y-M et al. Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study.
26 Finke J et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
27 Gratwohl A et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
28 Groop P-H et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
29 Gunell M et al. Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype .
30 Haarala A et al. Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study.
31 Hakala M et al. Nivelreuma .
32 Hakanen M. Childhood overweight - Predictors, Consequences and Prevention .
33 Hakanen M et al. FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity .
34 Hammar N et al. Migration and differences in dietary habits - a cross sectional study of Finnish twins in Sweden.
35 Higuchi T et al. Combined reporter gene PET and iron oxide MRI for monitoring survial and localization of transplanted cells in the rat heart .
36 Higuchi T et al. Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin .
37 Hintsanen M et al. Cloninger's temperament traits and preclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study .
38 Hintsanen M et al. Cloninger`s temperament traits and preclinical atheloschlerosis: The Cardiovascular Risk in Young Finns Study.
39 Hohenthal U. Community-Acquired Pneumonia in Adult Patients with Special Reference to Rapid Methods for Etiological Diagnosis .
40 Hohenthal U et al. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia .
41 Honka M-J et al. The Pro12A1a polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
42 Hulkkonen J et al. Polymorphism in the IL6 promoter region in associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.
43 Ilanne-Parikka P et al. Diabetes.
44 Ilanne-Parikka P et al. Diabetes .
45 Ilva T et al. Early markers of myocardial injury: cTnI is enough .
46 Iozzo P et al. Contribution of glucose tolerance and gender to cardiac adiposity.
47 Itälä-Remes M. Krooninen lymfaattinen leukemia (KLL).
48 Jackson CE et al. Albuminuria in chronic heart failure: prevalence and prognostic importance .
49 Jalava-Karvinen et al. Simultaneous quantitative analysis of FcgammaRI (CD64) and CR1 (CD35) in neutrophils in distinguishing between bacterial infections, viral infections, and flammatory diseases .
50 Jartti L et al. Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men.
51 Jartti T et al. Obesity, adipokines and asthma.
52 Jokela M et al. Urban/rural differences in body weight: Evidence for social selection and causation hypotheses in Finland .
53 Juonala M et al. Alcohol consumption is directly associated with carotid intima-media thickness in Finnish young adults. The Cardiovascular Risk in Young Finns Study.
54 Jylhävä J et al. Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: The Cardiovascular Risk in Young Finns Study.
55 Jylhävä J et al. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
56 Järveläinen H et al. Extracellular matrix molecules: Potential targets in pharmacotherapy .
57 Järvisalo MJ et al. Breast feeding in infancy and arterial endothelial function later in life. The Cardiovascular Risk in Young Finns Study.
58 Kaitosaari T et al. Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.
59 Kajander S et al. Low radiation dose imaging of myocardial perfusion and coranary with a hybrid PET/CT scanner .
60 Kallio K et al. Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke .
61 Kantola I. Iäkkään verenpainepotilaan hoito.
62 Karjalainen PP et al. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction.
63 Kauhanen S et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
64 Kauhanen SP et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
65 Kaunisto MA et al. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.
66 Kauppi MJ et al. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs .
67 Keltikangas-Järvinen L et al. DRD2 C32806T Modifies the effect of child-rearing environment on adulthood novelty seeking.
68 Kilhovd BK et al. Increased serum levels of methylglyoxal -derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women.
69 Kiss J et al. Non-invasive diagnosis of acute mesenteric ischaemia using PET.
70 Kiviniemi TO et al. High dose of red wine elicits enhanced inhibition of fibrinolysis.
71 Kjeldsen SE et al. Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
72 Knuuti J et al. Quantification of myocardial blood flow will reform detection of CAD .
73 Koivu H et al. Severe periprosthetic osteolytic lesions after the Ankle Evolutive System total ankle replacement.
74 Koivuviita N. Milloin pitää epäillä sekundaarista hypertensiota?
75 Koivuviita N et al. A case report: a patient with IgA nephropathy and coealic disease. Complete clinical remission following gluten-free diet .
76 Koivuviita N et al. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatc coronary artery disease.
77 Komar G et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness.
78 Korhonen P et al. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population .
79 Korhonen PE et al. Ankle-brachial index is lower in hypertensive than in normotensive inviduals in a cardiovascular risk population.
80 Korhonen PE et al. Waist circumference home measurement - a device to find out patients in cardiovascular risk.
81 Korkeila P et al. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study.
82 Koskenvuo JW et al. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
83 Koskinen J et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: The Cardiovascular Risk in Young Finns Study.
84 Koskinen T et al. Short-term heart rate variability in healthy young adults. The Cardiovascular Risk in Young Finns Study.
85 Koskinen T et al. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study.
86 Koukkunen H et al. FINAMI-tutkimus: Vanhusten sepelvaltimotauti kuormittaa merkittävästi terveydenhoitojärjestelmää.
87 Kovanen P et al. Dyslipidemiat.
88 Kröger N et al. Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
89 Kudomi N et al. Non-invasive estimation of hepatic glucose uptake from [18F] FDG PET images using tissue-derived input functions.
90 Kudomi N et al. Parametric renal blood flow imaging using (15O)H2O and PET.
91 Laaksonen MML et al. Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.
92 Laaksonen MML et al. Genetic lactase non-persistence, consumption of milk products and intakes of milk nutrients in Finns from childhood to young adulthood.
93 Lahtela H et al. Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?
94 Laitinen I et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
95 Lammintausta A et al. Stroke morbidity in Swedish- and Finnish-speaking populations of Turku, Finland .
96 Lapinleimu J et al. Expression of common familial dyslipidemias in early childhood .
97 Latva-Hirvelä J et al. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
98 Latva-Hirvelä J et al. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
99 Leino R. Erikoislääkärin uutiset: Gastroenterologia .
100 Leino R. Erikoislääkärin uutiset: Gastroenterologia .
101 Leskelä P et al. Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity .
102 Leskinen Y et al. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease .
103 Lindgren MM et al. Reduced fluoroquinolone susceptibility in salmonella enterica isolates from travelers, Finland.
104 Lindgren P et al. The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
105 Lindroos MM et al. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation .
106 Lindroos MM et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction .
107 Linko R et al. Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study.
108 Louhelainen M et al. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
109 Magnussen CG et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood.
110 Mann JFE et al. Effect of telmisartan on renal outcomes. A randomized trial.
111 Metsärinne K. Erikoislääkärin uutiset: Nefrologia.
112 Metsärinne K. Erikoislääkärin uutiset: Nefrologia .
113 Miettinen TA et al. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns Study.
114 Mikkilä V et al. Long-term dietary patterns and carotid artery intima media thickness: The Cardiovascular Risk in Young Finns Study.
115 Miller CD et al. Safety and efficacy of bivalirudin in high-risk patients admitted through the emergency department .
116 Minn H et al. 18F-FDOPA: A multiple-target molecule.
117 Montalescot G et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
118 Mustonen J et al. Johtamiskoulutusta pidetään tiedekunnissa tärkeänä .
119 Nekolla SG et al. PET and MRI in cardiac imaging: from validation studies to integrated applications .
120 Nekolla SG et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
121 Nesterov SV et al. Myocardial perfusion quantitation with 15 O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas TM) .
122 Niinikoski H et al. Blood pressure is lower in children and adolescents with a low-saturated-fat diet since infancy. The special Turku coronary risk factor intervention project.
123 Niiranen TJ et al. Home blood pressure has a stronger association with arterial stiffness than clinic blood pressure: the Finn-Home Study.
124 Nissinen K et al. Sweets and sugar-sweetened soft drink intake in childhood in relation to adult BMI and overweight. The Cardiovascular Risk in Young Finns Study.
125 Nurminen J et al. The use of chemical restraints for older long-term hospital patients: a case report from Finland.
126 Nuutila J et al. CRP/CD11b ratio: a novel parameter for detecting gram-positive sepsis.
127 Nuutila J et al. Comparison of degranulation of easily mobilizable intracellular granules by human phagocytes in healthy subjects and patients with infectious diseases .
128 Nymark M et al. Serum lipopolysaccharide activity is associated with the progression of kidney disease in Finnish patients with type 1 diabetes.
129 Okin PM et al. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment. The losartan intervention for end-point reduction in hypertension study (LIFE).
130 Pertovaara M et al. Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study.
131 Pessi T et al. CRP and FCGR2A genes have an epistatic effect on carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns Study.
132 Pikkarainen E, Viikari J. Vähäestrogeeniset ehkäisypillerit ja nuorten naisten luumassan kehitys.
133 Poulter NR et al. Baseline heart rate, antihypertensive treatment and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) .
134 Preiss D et al. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbility (CHARM) program.
135 Pulkki-Råback L et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study.
136 Puolakka K et al. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
137 Puolakka K et al. A mismatch between self-reported physical work load and the HAQ: early identification of rheumatoid arthritis patients at risk for loss of work productivity.
138 Putkonen M et al. Single-dose pegfilgrastim is comparable to daily filgrastim in moblilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies.
139 Puttonen S et al. Shift work in young adults and carotid artery intima-media thickness: The Cardiovascular Risk in Young Finns Study.
140 Raitakari OT et al. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
141 Raitakari OT et al. Pulse pressure in youth and carotid intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns Study.
142 Rantalaiho V et al. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time . The eleven-year results of the finnish rheumatoid arthritis combination therapy trial.
143 Remes K. Erikoislääkärin uutiset: Hematologia .
144 Erikoislääkärin uutiset: Hematologia .
145 Robinson SP et al. Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin´s lymphoma: identification of prognostic factors predicting outcome.
146 Rosengård-Bärlund M et al. Early autonomic dysfunction in type 1 diabetes: a reversible disorder?
147 Ruokonen E et al. Aikuisten vaikean sepsiksen hoito.
148 Ruokoniemi P et al. Acetazolamide may provoke cyclsporine toxicity - a case report .
149 Ruottinen S et al. Carbohydrate intake, serum lipids and apolipoprotein E phenotype show association in children.
150 Rönnemaa T. INR-arvon nousu eksenatidihoidon aikana.
151 Rönnemaa T. Lääkäritutkijat - häviävä voimavara?
152 Rönnemaa T. Minimed-glukoosisensori .
153 Rönnemaa T. Jatkuva verensokerimittaus .
154 Rönnemaa T. Jalkojen omaseuranta .
155 Rönnemaa T. Jalkojen päivittäinen hoito ja kynsien leikkaaminen .
156 Rönnemaa T. Kenkien ja sukkien valinta .
157 Rönnemaa T. Mistä diabeetikon jalkaongelmat johtuvat?
158 Rönnemaa T. Diabeetikon jalkaongelmille altistavia tekijöitä .
159 Rönnemaa T. Diabeetikon jalkaongelman laukaisevat tekijät .
160 Rönnemaa T. Neuropatiasta johtuvat haavaumat .
161 Rönnemaa T. Charcot´'n jalka eli neuroartropatia .
162 Rönnemaa T. Valtimoverenkierron häiriöt jaloissa diabeetikolla .
163 Rönnemaa T. Diabeetikon jalkavaurioiden jälkihoito .
164 Rönnemaa T. Miten ja miksi diabeteksen lisäsairauksia voi kehittyä? .
165 Rönnemaa T. Kohonnut verenpaine ja sen lääkehoito diabeetikolla .
166 Rönnemaa T. Kolesteroli- ja triglyseridiaineenvaihdunnan häiriöt ja niiden hoito diabeetikolla .
167 Rönnemaa T. Lisääntynyt hyytymistaipumus ja diabetes .
168 Rönnemaa T. Miksi diabeetikon sepelvaltimotautiriski on suurempi muita?
169 Rönnemaa T. Sepelvaltimotaudin oireet ja tutkimukset diabeetikolla .
170 Rönnemaa T. Sepelvaltimotaudin ehkäisy ja hoito .
171 Rönnemaa T. Sepelvaltimokohtaus (sydäninfarkti) ja diabetes .
172 Rönnemaa T. Aivoverenkiertohäiriöt ja diabetes.
173 Rönnemaa T. Miten, miksi ja milloin munuaisten toiminta voi häiriintyä?
174 Rönnemaa T. Miten munuaisten toimintaa tutkitaan?
175 Rönnemaa T. Nefropatian oireet .
176 Rönnemaa T. Nefropatian ehkäisy .
177 Rönnemaa T. Nefropatian hoito .
178 Rönnemaa T. Mitä on neuropatia?
179 Rönnemaa T. Neuropatiaoireet .
180 Rönnemaa T. Neuropatian tutkiminen .
181 Rönnemaa T. Neuropatian ehkäisy ja hoito .
182 Rönnemaa T. Diabetes ja iho.
183 Rönnemaa T. Erektiohäiriöt ja diabetes .
184 Rönnemaa T. Diabetekseen liittyvät yläraajaongelmat .
185 Rönnemaa T. Osteoporoosi ja diabetes .
186 Rönnemaa T. Diabetes ja kilpirauhanen .
187 Rönnemaa T. Diabetes ja keliakia .
188 Rönnemaa T. Diabeetikko leikkauksissa ja erityistutkimuksissa .
189 Rönnemaa T. Diabetes ja rokotukset .
190 Rönnemaa T . Jatkuvanäyttöiset glukoosisensorit .
191 Rönnemaa T . Muut munuaisongelmat .
192 Rönnemaa T, Huhtanen J. Jalkavammojen estäminen .
193 Rönnemaa T, Huhtanen J. Lievien jalkaongelmien hoito .
194 Rönnemaa T, Summanen P. Näköhäiriöt diabeteksen toteamisvaiheessa .
195 Rönnemaa T, Summanen P. Mitä tapahtuu verkkokalvosairaudessa eli retinopatiassa?
196 Rönnemaa T, Summanen P. Retinopatian ehkäisy.
197 Rönnemaa T, Summanen P. Retinopatian hoito.
198 Rönnemaa T, Summanen P. Harmaakaihi ja diabetes .
199 Saarelainen H et al. Flow mediated vasodilation and circulating concentrations of high sensitive C-reactive protein, interleukin-6 and tumor necrosis factor-alpha in normal pregnancy - The Cardiovascular Risk in Young Finns Study.
200 Salo TM et al. Fractal scaling properties of heart rate dynamics and myocardial efficiency in dilated cardiomyopathy.
201 Saraheimo M, Rönnemaa T. Pitkään diabetesta sairastaneen vanheneminen .
202 Saraheimo M, Rönnemaa T. Vanhuusiässä diabetekseen sairastuvan hoitotavoitteet .
203 Saraheimo M, Rönnemaa T. Vanhuusiässä tyypin 2 diabetekseen sairastuneen verensokeritasapainon hoito .
204 Saraheimo M, Rönnemaa T. Vanhuusiässä diabetekseen sairastuneen verensokerin seuranta .
205 Saraheimo M, Rönnemaa T. Lisäsairauksien ehkäisy vanhuusiässä tyypin 2 diabetekseen sairastuneilla.
206 Saraheimo M, Rönnemaa T. Korkean verensokerin aiheuttama tajuttomuus ilman happomyrkytystä .
207 Saraste A et al. Nuclear cardiology needs new "blood".
208 Saraste A et al. Cardiovascular molecular imaging: an overview .
209 Saraste A et al. Eteiskorvakkeen katetrisulku .
210 Schwaiger M et al. Myocardial innervation.
211 Sever PS et al. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension .
212 Sever PS et al. Coronary heart disease benefits from blood pressure and lipid-lowering .
213 Sherif HM et al. Evaluation of a novel 18 F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats .
214 Simell O et al. Cohort profile: the STRIP study (special Turku coronary risk factor intervention project), an infancy-onset dietary and life-style intervention trial.
215 Sivenius J et al. Modelling the burden of stroke in Finland until 2030.
216 Sleight P et al. Prognostic value of blood pressure in patients with high vascular risk in the ongoing telmisartan alone and in combination with ramipril global endpoint trial study.
217 Soininen P et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism.
218 Solomon SD et al. Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
219 Steinhubl SR et al. Aspirin to prevent cardiovascular disease: The association of aspirin dose and clopidogrel with thrombosis and bleeding.
220 Stenholm T et al. Methicillin-resistant Staphylococcus aureus screening by online immunometric monitoring of bacterial growth under selective pressure .
221 Strandberg T, Viikari J. Tulisiko CRP:tä mitata valtimotautiriskin määrittämiseksi?
222 Tenovuo J, Rönnemaa T. Diabetes ja suu .
223 Tertti R et al. Varjoaineet ja munuaisongelmat .
224 Tertti R et al. Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A.
225 Thorn LM et al. Effect of parental type 2 diabetes on offspring with type 1 diabetes.
226 Thorn LM et al. Metabolic syndrome as a risk factor for cardiovascular disease, mortality and progression of diabetic nephropathy in type 1 diabetes.
227 Toikka T et al. Onko diabeetikoiden jalkojen omahoito parantunut 20 vuoden aikana?
228 Toivonen R et al. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
229 Forsblom C et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes .
230 Tuominen S et al. Potilaiden kokemukset nivelreuman aiheuttamasta haitasta .
231 Ukkonen H et al. Cardiovascular drug develpoment using radiopharmaceuticals .
232 Ukkonen H et al. The effect of right ventricular pacing on myocardial oxidative metabolism and efficiency: relation with left ventricular dyssynchrony.
233 Valleala H et al. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.
234 Valtonen P et al. Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy.
235 Varis J et al. Experiences of telemedicine-aided hypertension control in the follow-up of Finnish hypertensive patients.
236 Varis J et al. Treatment of hypertension in Finnish general pratctice seems unsatisfactory despite evidence-based guidelines.
237 Verdecchia P et al. Effects of telmisartan, ramipril and their combination on left ventricular hypertrophy in individuals at high vascular risk in the ongoing telmisartan alone and in combination with ramipril global end point trial etc.
238 Viikari J. Onko lääketeollisuudella sijaa lääkäreiden koulutuksessa? "Kyllä on. Mitä tahansa luentoa on kuunneltava kriittisesti.".
239 Viikari J. Valtimotaudin kokonaisriskin arviointi ja potilaan motivoiminen hoitoon .
240 Viikari J et al. The initiatives and outcomes for cardiovascular risks that can be achieved through paediatric counselling.
241 Viljanen A. Effects of Weight Loss on Adipose Tissue, Liver and Heart Metabolism in Humans. Studies with PET, MRI ja MRS.
242 Viljanen APM et al. Effects of weight loss on liver free fatty acid uptake and hepatic insulin resistance.
243 Viljanen APM et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance.
244 Viljanen APM et al. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults.
245 Viljanen APM et al. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects .
246 Virtanen KA et al. Functional brown adipose tissue in healthy adults.
247 Voors AA et al. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study .
248 Wadén J et al. A1C variability predicts incident cardiovascular events, microalbuminuria and overt diabetic nephropathy in patients with type 1 diabetes.
249 Wadén J et al. Adult stature and diabetes complications in patients with type 1 diabetes. The FinnDiane Study and the diabetes control and complications trial.
250 Wallentin L et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes .
251 Yang X et al. Sustained participation in youth sport decreases metabolic syndrome in adulthood.
Julkaisutietokanta 26.8.2010 Publications Data Base 26.8.2010